These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

185 related items for PubMed ID: 3051578

  • 1. Antirejection treatment with anti-thymocyte globulin in renal transplant recipients treated with cyclosporine as basic immunosuppression.
    Hoitsma AJ, Wetzels JF, Berden JH, Koene RA.
    Transplant Proc; 1988 Oct; 20(5 Suppl 6):12-3. PubMed ID: 3051578
    [No Abstract] [Full Text] [Related]

  • 2. OKT3 treatment of steroid- and/or anti-thymocyte globulin-resistant renal allograft rejection occurring on triple baseline immunosuppression including cyclosporine A.
    Widmer U, Frei D, Keusch G, Burger HR, Largiader F, Binswanger U.
    Transplant Proc; 1988 Oct; 20(5 Suppl 6):90-5. PubMed ID: 3140454
    [No Abstract] [Full Text] [Related]

  • 3. Comparison of 10-day and 21-day ATG-antirejection treatment in renal transplant patients treated with either cyclosporine or azathioprine as basic immunosuppression.
    Hoitsma AJ, Tiggeler RG, Wetzels JF, Berden JH, Koene RA.
    Transplant Proc; 1989 Feb; 21(1 Pt 2):1732-3. PubMed ID: 2652566
    [No Abstract] [Full Text] [Related]

  • 4. Antilymphoblast globulin treatment of steroid-resistant rejection in cyclosporine-immunosuppressed renal transplant recipients.
    Tellis VA, Matas AJ, Quinn TA, Glicklich D, Weiss RJ, Soberman RJ, Veith FJ.
    Transplant Proc; 1987 Feb; 19(1 Pt 3):1892. PubMed ID: 3274447
    [No Abstract] [Full Text] [Related]

  • 5. Rabbit anti-thymocyte globulin treatment of steroid resistant rejection in renal allograft recipients immunosuppressed with cyclosporine A.
    O'Donoghue DJ, Johnson RW, Mallick NP, Gokal R, Ballardie FW, Bakran A, Pearson R, Scott P.
    Transplant Proc; 1989 Feb; 21(1 Pt 2):1736-7. PubMed ID: 2652568
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Conversion of cyclosporine to azathioprine in renal transplant patients.
    Shen SY, Zemel SM, Weir MR, Dagher FJ, Bentley FR.
    Transplant Proc; 1987 Feb; 19(1 Pt 3):2032-6. PubMed ID: 3547906
    [No Abstract] [Full Text] [Related]

  • 8. Alternative antirejection treatment with steroids or antilymphoblast globulin in renal transplant patients receiving cyclosporine.
    Veremis SA, Maddux MS, Pollak R, Kline SS, Mozes MF.
    Transplant Proc; 1987 Feb; 19(1 Pt 3):1893-5. PubMed ID: 3079056
    [Abstract] [Full Text] [Related]

  • 9. Contribution of T-cell subset monitoring of renal transplant recipients in the cyclosporine era.
    Khanuja PS, Toledo-Pereyra LH, Gordon DA, Bandlien KO, Whitten JI.
    Transplant Proc; 1989 Feb; 21(1 Pt 2):1852-3. PubMed ID: 2652602
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Comparison of immunosuppression therapy following heart transplantation: pretransfusion/azathioprine/ATG/prednisone versus cyclosporine/prednisone.
    Barnhart GR, Goldman MH, Hastillo A, Szentpetery S, Wolfgang T, Thompson J, Mohanakumar T, Katz MR, Rider S, Hanrahan J.
    J Heart Transplant; 1985 Feb; 4(4):381-4. PubMed ID: 3916511
    [Abstract] [Full Text] [Related]

  • 13. Use of cyclosporine and Minnesota antilymphoblast globulin in the early postoperative treatment of primary cadaveric renal transplant recipients.
    Kupin W, Venkat KK, Oh HK, Dienst S, Levin NW.
    Transplant Proc; 1987 Feb; 19(1 Pt 3):1882-5. PubMed ID: 3547893
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. A comparison of renal biopsies in cyclosporine and conventionally immunosuppressed renal transplant recipients.
    Simonton SC, Sibley RK, Fryd DS.
    Transplant Proc; 1987 Feb; 19(1 Pt 2):1790. PubMed ID: 3079038
    [No Abstract] [Full Text] [Related]

  • 17. Reversal of cardiac transplant rejection without massive immunosuppression.
    Michler RE, Smith CR, Drusin RE, Reison DS, Hickey TJ, Lamb J, Reemtsma K, Rose EA.
    Circulation; 1986 Nov; 74(5 Pt 2):III68-71. PubMed ID: 3533317
    [Abstract] [Full Text] [Related]

  • 18. Effect of prophylaxis with low-dose anti-thymocyte globulin on prevention of acute kidney allograft rejection.
    Khosroshahi HT, Tubbs RS, Shoja MM, Ghafari A, Noshad H, Ardalan MR.
    Transplant Proc; 2008 Nov; 40(1):137-9. PubMed ID: 18261569
    [Abstract] [Full Text] [Related]

  • 19. Immunologic monitoring parameters in ALG- versus non-ALG-treated renal transplant patients.
    McAlack RF, Stern S, Beizer R, Sklar L, Bannett A.
    Transplant Proc; 1979 Jun; 11(2):1431-2. PubMed ID: 382532
    [No Abstract] [Full Text] [Related]

  • 20. Predictive value of IgG subclass levels for infectious complications in renal transplant recipients.
    Wieneke H, Otte B, Lang D, Heidenreich S.
    Clin Nephrol; 1996 Jan; 45(1):22-8. PubMed ID: 8616953
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.